天境生物 IMAB 深 滬
等待開盤 01-29 09:30:00 美东时间
4.63
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 4.63
- 總市值 5.32亿
- 52周最高 6.79
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.595
- 委 比 0.00%
- 總股本 1.15亿
- 歷史最高 85.40
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.595
- 每 手 1
- 風險率 1.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Sanofi's Amlitelimab Confirms Potential In Atopic Dermatitis
BRIEF-Sanofi's Amlitelimab Confirms Potential In Atopic Dermatitis Jan 23 (Reuters) - Sanofi SA SASY.PA : AMLITELIMAB CONFIRMS ITS POTENTIAL IN ATOPIC DERMATITIS AQUA AND ESTUARY STUDIES TO REPORT RESULTS IN H2 2026 AMLITELIMAB MEETS ALL PRIMARY AND SECONDARY ENDPOINTS IN SHORE STUDY Source text: ID
01-23 14:13
刚刚！天境生物与之科控股达成超长效创新药合作
（来源：药研网） 2025年12月26日，天境生物宣布，与之江实验室科技控股有限公司(以下简称"之科控股")签署合作协议，携手应用之江实验室科技成果，推进包括生...
2025-12-26 17:29
新桥生物IPO前未盈利，康桥资本傅唯走向台前
（来源：预审IPO） 文/瑞财经 刘治颖 “分家”一年多后，傅唯掌舵的新桥生物开启全球转型。 作为一位经验丰富的操盘手，傅唯曾在麦格理、渣打等知名机构任职。...
2025-12-02 13:30
新桥生物(NBP)，递交IPO招股书，拟赴香港上市，高盛、中信证券联席保荐 | 中概股香港上市
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 2025年10月30日，新桥生物NovaBridge Bi...
2025-10-31 14:13
I-Mab Changes Name To NovaBridge Biosciences; To Trade Under New Name, NBP Ticker, Effective Oct. 30
NovaBridge Biosciences (NovaBridge or the Company) today announced that it has changed its corporate name from I-Mab to NovaBridge Biosciences. The change was overwhelmingly approved by shareholders at the Company's
2025-10-29 21:20
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform
NovaBridge Biosciences (formerly I-Mab) rebranded as a global biotech platform to accelerate innovative medicines. The company plans a Hong Kong IPO, aiming for dual listings on Nasdaq and HKEX. It formed Visara, acquiring VIS-101 for treating wet AMD and DME. Its core asset, givastomig, a Claudin 18.2 X 4-1BB bispecific antibody, advances toward Phase 2. The rebranding reflects NovaBridge's strategic expansion and commitment to global health inn...
2025-10-29 13:00
I-MAB Completes Acquisition of Bridge Health Biotech
I-MAB ( ($IMAB) ) has issued an announcement. On October 28, 2025, I-MAB announ...
2025-10-29 04:44
美股大行评级 | 升至45美元！英特尔获多家机构上调目标价；大摩上调拖拉机供应公司(TSCO)评级至"标配"，目标价升至60美元
今日重点评级关注：HC Wainwright & Co.：维持Alto Neuroscience"买入"评级，目标价从10美元升至50美元；RBC Capital：维持Precision Drilling"跑赢大市"评级，目标价从110美元升至117美元
2025-10-27 09:45
I-Mab Rebrands to NovaBridge Biosciences Following Shareholder Approval
An update from I-MAB ( ($IMAB) ) is now available. On October 24, 2025, I-Mab h...
2025-10-25 04:50
